Clinical Trial Update: Atomoxetine in Veterans With Comorbid ADHD/PTSD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating atomoxetine in veterans with comorbid ADHD and PTSD; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Post Traumatic Stress Disorder, Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2019-04-03